| Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non–small-cell lung cancer: a competing risks analysis T Eguchi, S Bains, MC Lee, KS Tan, B Hristov, DH Buitrago, MS Bains, ... Journal of Clinical Oncology 35 (3), 281-290, 2017 | 194 | 2017 |
| Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score–matched analysis T Eguchi, K Kameda, S Lu, MJ Bott, KS Tan, J Montecalvo, JC Chang, ... Journal of thoracic oncology 14 (1), 87-98, 2019 | 189 | 2019 |
| Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer–specific death in squamous cell carcinoma S Lu, KS Tan, K Kadota, T Eguchi, S Bains, N Rekhtman, PS Adusumilli, ... Journal of Thoracic Oncology 12 (2), 223-234, 2017 | 164 | 2017 |
| Pathologic assessment after neoadjuvant chemotherapy for NSCLC: importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma Y Qu, K Emoto, T Eguchi, RG Aly, H Zheng, JE Chaft, KS Tan, DR Jones, ... Journal of Thoracic Oncology 14 (3), 482-493, 2019 | 106 | 2019 |
| The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know T Eguchi, K Kadota, BJ Park, WD Travis, DR Jones, PS Adusumilli Seminars in thoracic and cardiovascular surgery 26 (3), 210-222, 2014 | 104 | 2014 |
| V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural … S Muller, WV Lai, PS Adusumilli, P Desmeules, D Frosina, A Jungbluth, ... Modern Pathology 33 (2), 303-311, 2020 | 89 | 2020 |
| Tumor size and computed tomography attenuation of pulmonary pure ground-glass nodules are useful for predicting pathological invasiveness T Eguchi, A Yoshizawa, S Kawakami, H Kumeda, T Umesaki, H Agatsuma, ... PLoS One 9 (5), e97867, 2014 | 89 | 2014 |
| Spread through air spaces (STAS) is prognostic in atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma of the lung RG Aly, N Rekhtman, X Li, Y Takahashi, T Eguchi, KS Tan, CM Rudin, ... Journal of Thoracic Oncology 14 (9), 1583-1593, 2019 | 81 | 2019 |
| Three-dimensional histologic, immunohistochemical, and multiplex immunofluorescence analyses of dynamic vessel co-option of spread through air spaces in lung adenocarcinoma Y Yagi, RG Aly, K Tabata, A Barlas, N Rekhtman, T Eguchi, J Montecalvo, ... Journal of Thoracic Oncology 15 (4), 589-600, 2020 | 76 | 2020 |
| Three-dimensional imaging navigation during a lung segmentectomy using an iPad T Eguchi, K Takasuna, A Kitazawa, Y Fukuzawa, Y Sakaue, K Yoshida, ... European journal of cardio-thoracic surgery 41 (4), 893-897, 2012 | 69 | 2012 |
| Computed tomography attenuation predicts the growth of pure ground-glass nodules T Eguchi, R Kondo, S Kawakami, M Matsushita, A Yoshizawa, D Hara, ... Lung Cancer 84 (3), 242-247, 2014 | 65 | 2014 |
| Tumor spread through air spaces is a predictor of occult lymph node metastasis in clinical stage IA lung adenocarcinoma RG Vaghjiani, Y Takahashi, T Eguchi, S Lu, K Kameda, Z Tano, J Dozier, ... Journal of Thoracic Oncology 15 (5), 792-802, 2020 | 57 | 2020 |
| Procedure-specific risk prediction for recurrence in patients undergoing lobectomy or sublobar resection for small (≤ 2 cm) lung adenocarcinoma: an international cohort analysis S Bains, T Eguchi, A Warth, YC Yeh, J Nitadori, KM Woo, TY Chou, ... Journal of Thoracic Oncology 14 (1), 72-86, 2019 | 55 | 2019 |
| Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy H Zheng, M Zeltsman, MG Zauderer, T Eguchi, RG Vaghjiani, ... Immunotherapy 9 (11), 913-927, 2017 | 50 | 2017 |
| Expansion of the concept of micropapillary adenocarcinoma to include a newly recognized filigree pattern as well as the classical pattern based on 1468 stage I lung adenocarcinomas K Emoto, T Eguchi, KS Tan, Y Takahashi, RG Aly, N Rekhtman, WD Travis, ... Journal of Thoracic Oncology 14 (11), 1948-1961, 2019 | 48 | 2019 |
| Usefulness of vessel-sealing devices for≤ 7 mm diameter vessels: a randomized controlled trial for human thoracoscopic lobectomy in primary lung cancer M Toishi, K Yoshida, H Agatsuma, T Sakaizawa, T Eguchi, G Saito, ... Interactive cardiovascular and thoracic surgery 19 (3), 448-455, 2014 | 47 | 2014 |
| Persistent and aggressive treatment for thymic carcinoma: Results of a single-institute experience with 25 patients R Maruyama, R Suemitsu, T Okamoto, M Kojo, Y Aoki, H Wataya, ... Oncology 70 (5), 325-329, 2007 | 44 | 2007 |
| Implications of the eighth edition of the TNM proposal: invasive versus total tumor size for the T descriptor in pathologic stage I-IIA lung adenocarcinoma K Kameda, T Eguchi, S Lu, Y Qu, KS Tan, K Kadota, PS Adusumilli, ... Journal of Thoracic Oncology 13 (12), 1919-1929, 2018 | 43 | 2018 |
| Competing risks and cancer-specific mortality: why it matters KS Tan, T Eguchi, PS Adusumilli Oncotarget 9 (7), 7272, 2018 | 39 | 2018 |
| Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1 T Eguchi, K Kadota, M Mayor, MG Zauderer, A Rimner, VW Rusch, ... Oncotarget 8 (44), 77872, 2017 | 36 | 2017 |
